Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Name
Chauhan_2013-Angiotensin inhibition enhances.pdf
Size
1.07 MB
Format
Adobe PDF
Checksum (MD5)
690cc98fe8079cb27cf3b0fb2d31430a
Author(s)
Chauhan, Vikash P.
Liu, Hao
Lacorre, Delphine A.
Jain, Saloni R.
Kozin, Sergey V.
Stylianopoulos, Triantafyllos
Mousa, Ahmed S.
Han, Xiaoxing
Adstamongkonkul, Pichet
Huang, Peigen
Date Issued
October 2013
Journal
Nature Communications
Publisher
Nature Publishing Group
Citation
Chauhan, Vikash P., John D. Martin, Hao Liu, Delphine A. Lacorre, Saloni R. Jain, Sergey V. Kozin, Triantafyllos Stylianopoulos, et al. “Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.” Nature Communications 4 (October 1, 2013). © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited
Version
Final published version
Abstract
Cancer and stromal cells actively exert physical forces (solid stress) to compress tumour blood vessels, thus reducing vascular perfusion. Tumour interstitial matrix also contributes to solid stress, with hyaluronan implicated as the primary matrix molecule responsible for vessel compression because of its swelling behaviour. Here we show, unexpectedly, that hyaluronan compresses vessels only in collagen-rich tumours, suggesting that collagen and hyaluronan together are critical targets for decompressing tumour vessels. We demonstrate that the angiotensin inhibitor losartan reduces stromal collagen and hyaluronan production, associated with decreased expression of profibrotic signals TGF-β1, CCN2 and ET-1, downstream of angiotensin-II-receptor-1 inhibition. Consequently, losartan reduces solid stress in tumours resulting in increased vascular perfusion. Through this physical mechanism, losartan improves drug and oxygen delivery to tumours, thereby potentiating chemotherapy and reducing hypoxia in breast and pancreatic cancer models. Thus, angiotensin inhibitors—inexpensive drugs with decades of safe use—could be rapidly repurposed as cancer therapeutics.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Massachusetts Institute of Technology. Department of Chemistry
Terms of Use
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1038/ncomms3516
